In conventional MALDI, laser irradiation of the matrix-analyte co-crystallized target causes the matrix to absorb energy and promote desorption and partial ionization of the analyte; however, a large number of molecules enter the gas-phase plume as neutrals and are never converted into detectable ions, limiting sensitivity and molecular coverage. MALDI-2 adds a second laser in the desorption plume immediately adjacent to the target, specifically triggering secondary ionization of these neutral molecules.
The second laser typically uses a wavelength that does not match matrix absorption; its energy is mainly absorbed by the neutral analyte or the medium in the desorption plume, producing photoionization or electron-mediated ionization events that convert the otherwise escaping neutral molecules into ions collected by the mass analyzer. This process does not alter the spatial sampling of MALDI and preserves the original pixel resolution.
In biological tissue mass spectrometry imaging, lipids, glycolipids, metabolites, and some peptides yield low ion currents under conventional MALDI, and their signals often fall below the detection threshold. By capturing neutral molecules in the plume, MALDI-2 brings these invisible species into detection, significantly increasing the number of quantifiable molecular species on the same tissue section.
The gain is molecularly selective: it is most pronounced for neutral molecules that are difficult to protonate or deprotonate (such as certain lipid classes); the gain is limited for matrix adduct peaks that already show strong signals under conventional MALDI. Therefore MALDI-2 is often used as a complementary acquisition mode to conventional MALDI, for mining weak-signal pathways rather than replacing the main imaging.
MALDI-2 is mostly used on lipid-rich sections such as brain and tumor tissues to expand the molecular dimension of metabolic and lipid spatial maps; it is also valuable in drug distribution and metabolite localization studies. Coupled with high-resolution Orbitrap or TOF platforms, it can improve the signal-to-noise ratio of low-abundance molecules while maintaining subcellular to tens-of-micrometers spatial resolution.
The limitation is that the second laser introduces additional parameters (energy, timing, focal spot), making method development more complex; moreover, post-ionization may enhance background matrix signals, requiring optimization of matrix and laser timing to balance gain and noise. In addition, this capability is mostly provided as a module and must be paired with a MALDI imaging system that has the corresponding laser interface.
MALDI-2 belongs to the desorption post-ionization enhancement approach and overlaps in objective with Neo-Source LDPI's laser desorption photoionization and DPI's dual photoionization - all aim to improve detection of weak-signal molecules, but the implementation paths differ: MALDI-2 relies on matrix desorption plus a second laser, while LDPI/DPI emphasize photoionization in a matrix-free environment.
Selection should integrate the polarity of the analyte, whether matrix sample preparation is acceptable, and host-platform compatibility. For scenarios requiring matrix-free, in-situ, and ambient conditions, matrix-free imaging sources such as LDPI/DPI can be compared; for users with existing MALDI imaging systems who want to expand weak-signal coverage, the MALDI-2 module is a lower-modification-cost path.
To obtain detailed specifications, compatible models, or a quotation for the MSI LDPI / DPI full series imaging ion sources, visit the Neo-Source official website, or contact the official team for compatibility advice tailored to your mass spectrometer (Agilent / SCIEX / Thermo and other mainstream MS).